There was a LOT of good stuff in that press releas
Post# of 72446
Posted On: 07/07/2016 8:57:49 AM
There was a LOT of good stuff in that press release. Some excerpts:
It seems clear that they are NOT going to make the foolish mistakes other companies have made, of overpromoting their results, and trying to hurry the trials -- and ending up either injuring people (remember that company in France that killed the previously healthy volunteer?) or screwing up the trial by trying to move too fast (remember why Brilacidin "failed" the first time? because they gave huge doses and there were side effects at those extremely high amounts).
So now we know why an experienced guy like this was brought in. He's making sure the clinical trials will be run in a way that will make Big Pharma understand what we've got.
Quote:
"recruiting additional leading industry veterans for our staff and advisory board...
the Company has fielded inquiries from many interested parties about the compound and has evaluated several options for the next stage of development.
...Benefits were apparent by two weeks ...... [that is INCREDIBLY fast]
The Company intends to increase the dosing beyond 200mg and evaluate patients using the Psoriasis Area and Severity Index (PASI) scoring method, which will enable better comparison to approved psoriasis drugs, including apremilast and biologics.
multiple secondary endpoints will be studied to provide insights regarding additional potential benefits of Prurisol compared to approved therapies.
It seems clear that they are NOT going to make the foolish mistakes other companies have made, of overpromoting their results, and trying to hurry the trials -- and ending up either injuring people (remember that company in France that killed the previously healthy volunteer?) or screwing up the trial by trying to move too fast (remember why Brilacidin "failed" the first time? because they gave huge doses and there were side effects at those extremely high amounts).
So now we know why an experienced guy like this was brought in. He's making sure the clinical trials will be run in a way that will make Big Pharma understand what we've got.
(5)
(0)